Wai-In Chan

1.8k citations
6 papers · 135 indexed · h-index 5
Topics
Acute Myeloid Leukemia Research (3 papers)Neuroblastoma Research and Treatments (1 paper)Chemotherapy-induced cardiotoxicity and mitigation (1 paper)

In The Last Decade

Wai-In Chan

6 papers receiving 135 citations

Peers

Wai-In Chan
Comparison fields: 5 of 44
  • Molecular Biology 81
  • Hematology 53
  • Oncology 25
  • Immunology 23
  • Public Health, Environmental and Occupational Health 12
Replace Selina Qiuying Liu with:
Selina Qiuying Liu United States
Claudia Lanauze United States
Sorcha O’Byrne United Kingdom
Konstanze Doehner Germany
Malika Kapadia United States
Itziar Cossío Spain
Fabrizio Simeoni United Kingdom
Bettina Moehrle Germany
Nelli Frank Austria
Louise N Winteringham Australia
Wai-In Chan relative to Selina Qiuying Liu United States Selina Qiuying Liu's profile →
Citations per field
00.5×
Selina Qiuying Liu · 1×
Citations per year

Countries citing papers authored by Wai-In Chan

Since Specialization
Citations

This map shows the geographic impact of Wai-In Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wai-In Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wai-In Chan more than expected).

Fields of papers citing papers by Wai-In Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wai-In Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wai-In Chan. The network helps show where Wai-In Chan may publish in the future.

Co-authorship network of co-authors of Wai-In Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Wai-In Chan. A scholar is included among the top collaborators of Wai-In Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wai-In Chan. Wai-In Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 26
2 23
3 25
4 1
5 47
6
Studies of myeloperoxidase gene expression at the cellular level by in situ hybridization.
13

About Wai-In Chan

Wai-In Chan is a scholar working on Hematology, Immunology and Rheumatology, having authored 6 papers that have together received 135 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Neuroblastoma Research and Treatments (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Hematology (53 citations), Molecular Biology (81 citations) and Immunology (23 citations). Wai-In Chan has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Brian J.P. Huntly, Liang Liu, David J. Adams, Sherif R. Zaki, Patricia W. Greer, W. Craig Hooper, Paolo Gallipoli, David C. Swan, Bruce L. Evatt and Garth E. Austin. Their work appears in journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026